Cooper G J, Leighton B, Dimitriadis G D, Parry-Billings M, Kowalchuk J M, Howland K, Rothbard J B, Willis A C, Reid K B
Department of Biochemistry, University of Oxford, England.
Proc Natl Acad Sci U S A. 1988 Oct;85(20):7763-6. doi: 10.1073/pnas.85.20.7763.
Diabetes-associated peptide has recently been isolated and characterized from the amyloid of the islets of Langerhans in type 2 (non-insulin-dependent) diabetics, and immunoreactivity with antibodies to the peptide has been demonstrated in islet B cells of both normal and type 2 diabetic subjects. In view of the evidence presented in this paper that this 37-amino acid peptide may be a hormone present in normal individuals, we now propose the name "amylin" to replace "diabetes-associated peptide." Because increased amylin, deposited as amyloid within the islets of Langerhans, is characteristic of type 2 diabetes, the study below was performed to examine the possible effects of amylin on peripheral glucose metabolism. Whole amylin was synthesized by using solid-phase techniques, with formation of the disulfide linkage by oxidation in dilute aqueous solution and recovery of the peptide by lyophilization. The effects of amylin on glucose metabolism were studied in two preparations in vitro, isolated rat soleus muscle strips and isolated rat adipocytes. In skeletal muscle exposed to 120 nM amylin for 1 hr, there was a marked decrease in both basal and submaximally insulin-stimulated rates of glycogen synthesis, which resulted in significant reduction in the rates of insulin-stimulated glucose uptake. In muscles treated with amylin there was no response at the concentration of insulin required to stimulate glucose uptake half-maximally in untreated (control) muscles. In marked contrast, amylin had no effect on either basal or insulin-stimulated rates of glucose incorporation into either CO2 or triacylglycerol in isolated adipocytes. Therefore, amylin may be a factor in the etiology of the insulin resistance in type 2 diabetes mellitus, as both deposition of the peptide in islet amyloid and decreased rates of glucose uptake and glycogen synthesis in skeletal muscle are characteristic of this condition.
最近已从2型(非胰岛素依赖型)糖尿病患者胰岛淀粉样蛋白中分离并鉴定出糖尿病相关肽,并且在正常人和2型糖尿病患者的胰岛B细胞中均已证实该肽与抗体的免疫反应性。鉴于本文提供的证据表明这种37个氨基酸的肽可能是正常个体中存在的一种激素,我们现在提议用“胰淀素”这个名称来取代“糖尿病相关肽”。由于在朗格汉斯胰岛内沉积为淀粉样蛋白的胰淀素增加是二型糖尿病的特征,因此进行了以下研究以检查胰淀素对外周葡萄糖代谢的可能影响。采用固相技术合成了完整的胰淀素,通过在稀水溶液中氧化形成二硫键,并通过冻干回收肽。在两种体外制剂,即分离的大鼠比目鱼肌条和分离的大鼠脂肪细胞中研究了胰淀素对葡萄糖代谢的影响。在暴露于120 nM胰淀素1小时的骨骼肌中,基础和次最大胰岛素刺激的糖原合成速率均显著降低,这导致胰岛素刺激的葡萄糖摄取速率显著降低。在用胰淀素处理的肌肉中,在未处理(对照)肌肉中刺激葡萄糖摄取达到半最大所需的胰岛素浓度下没有反应。形成鲜明对比的是,胰淀素对分离的脂肪细胞中基础或胰岛素刺激的葡萄糖掺入二氧化碳或三酰甘油的速率均无影响。因此,胰淀素可能是2型糖尿病胰岛素抵抗病因中的一个因素,因为该肽在胰岛淀粉样蛋白中的沉积以及骨骼肌中葡萄糖摄取和糖原合成速率的降低都是这种疾病的特征。